News

Keeping you current on new and follow-on investments, portfolio product and service milestones, publications and events, management and board transitions, and other developments in Tullis funds.

September

6

TriSalus Life Sciences Appoints Jodi Devlin as President of TriSalus Therapeutics

Devlin Brings Significant Expertise in Commercialization, Sales and Marketing DENVER–(BUSINESS WIRE)–Sep. 6, 2023– TriSalus...

20

TriSalus Life Sciences Provides Updates on Pressure-Enabled Regional Immuno-Oncology™ (PERIO™) 01 and 02 Clinical Studies

Data further substantiates potential to significantly improve immunotherapy outcomes for patients with liver and...

12

TriSalus Life Sciences Opens Its First Research Laboratory on Lifespan Health System’s Campus

Immunotherapeutic collaboration will advance efforts to develop new treatment options for patients with liver...

7

TriSalus Life Sciences Announces First Patient Enrolled in PERIO-01 Clinical Trial to Evaluate Delivery of SD-101 via Pressure-Enabled Drug Delivery in Uveal Melanoma Liver Metastases

Study to evaluate the delivery of SD-101, an investigational TLR9 agonist, in combination with...

9

TriSalus Life Sciences Receives Expanded Reimbursement Authorization from CMS for TriNav Infusion System

Transitional Pass Through Payment (TPT) Facilitates Patient Access to New and Innovative Products That...

22

TriSalus Life Sciences Appoints Trevor McCaw as Chief Commercial Officer

Experienced commercial leader solidifies Company’s management team as it integrates novel therapies with innovative...

29

TriSalus Life Sciences Appoints Steven Katz, M.D., Chief Medical Officer

Renowned surgeon, clinician, and researcher to advance work to combine novel immuno-oncology therapies with...

Recent developments

News

September

6

TriSalus Life Sciences Appoints Jodi Devlin as President of TriSalus Therapeutics

November

20

TriSalus Life Sciences Provides Updates on Pressure-Enabled Regional Immuno-Oncology™ (PERIO™) 01 and 02 Clinical Studies

April

12

TriSalus Life Sciences Opens Its First Research Laboratory on Lifespan Health System’s Campus

September

7

TriSalus Life Sciences Announces First Patient Enrolled in PERIO-01 Clinical Trial to Evaluate Delivery of SD-101 via Pressure-Enabled Drug Delivery in Uveal Melanoma Liver Metastases

February

9

TriSalus Life Sciences Receives Expanded Reimbursement Authorization from CMS for TriNav Infusion System

October

22

TriSalus Life Sciences Appoints Trevor McCaw as Chief Commercial Officer

September

29

TriSalus Life Sciences Appoints Steven Katz, M.D., Chief Medical Officer